Preclinical efficacy of growth hormone-releasing hormone antagonist MIA-602 for androgen-dependent and castration-resistant human prostate cancer.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ferenc G. Rick, Cale D. Fahrenholtz, Maria I. Garcia, Norman L. Block, Andrew V. Schally, Kerry L. Burnstein
Institutions: Miami VA Healthcare System, University of Miami
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589233872